Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of S-ketamine on postoperative analgesia in open abdominal tumor surgery
ChiCTR2200055517Phase 4Not yet recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: visual analogue scale, dosage of analgesics within 48 hours after the operation and 1 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200055517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055517.